Inhibitor - PDFSEARCH.IO - Document Search Engine

Inhibitor
Results: 3217

#	Item
301	Avaxia Biologics Appoints Deborah S. Hartman, Ph.D. as Vice President, Research LEXINGTON, Mass. – March 26, 2013 – Avaxia Biologics, Inc., a clinical-stage biopharmaceutical company developing gut-targeted therapeut Add to Reading List Source URL: www.avaxiabiologics.com Language: English - Date: 2014-02-06 00:38:28 Monoclonal antibodies AstraZeneca Södertälje Municipality Biologic Pharmaceutical industry TNF inhibitor Pharmacology Pharmaceutical sciences Biotechnology
302	Toxicity from Checkpoint Inhibitors James Larkin FRCP PhD Disclosures Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2015-05-04 13:05:47 CTLA-4 Protein kinase inhibitor Bristol-Myers Squibb Ipilimumab Melanoma
303	Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixi Add to Reading List Source URL: www.mothertobaby.org Language: English - Date: 2015-06-08 18:15:35 Monoclonal antibodies Immunosuppressants Centocor Infliximab Schering-Plough Autoimmune diseases Pregnancy TNF inhibitor Vaccine Medicine Biology Health
304	Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference Positive Antiviral Responses Demonstrated in Interim 16 Week Analysis from SPRING-1 S Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:22 Medicine HIV/AIDS Cyclopropanes Integrase inhibitors Amides Lamivudine Zidovudine Antiretroviral drug GlaxoSmithKline Chemistry Organic chemistry Organofluorides
305	Skin Side Effects Christiane Thallinger, MD UNIVERSITY OF VIENNA, DEPARTMENT OF ONCOLOGY, GENERAL HOSPITAL VIENNA Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2015-05-04 13:05:43 Organofluorides Orphan drugs Amides Organochlorides Pyridines Sorafenib Chemotherapy-induced acral erythema Protein kinase inhibitor Sunitinib Chemistry Organic chemistry Medicine
306	Data from the FLAMINGO Phase IIIb/IV Study of the Integrase Inhibitor Tivicay® (dolutegravir), Disclosed by ViiV Healthcare Osaka, Japan, September 13, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: I Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:11 Sulfonamides Medicine Carbamates Darunavir HIV/AIDS Antiretroviral drug ViiV Healthcare Zidovudine Integrase inhibitor Protease inhibitors Chemistry Biology
307	Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting WALTHAM, Mass., May 1, 2015 – Kala Pharmaceuticals, Inc. (Kala), a developer of innovative ophthalmic prod Add to Reading List Source URL: kalarx.com Language: English - Date: 2015-05-11 17:04:35 Tyrosine kinase Vascular endothelial growth factor Tyrosine-kinase inhibitor Medicine Ophthalmology Protein kinase inhibitor
308	April 16, 2010 Shionogi & Co., Ltd. Eli Lilly Japan K.K. Launch of an Antidepressant Drug, “Cymbalta® Capsules 20mg and 30mg” Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President: Isao Teshirogi; hereafter “ Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Amines Phenols Serotonin-norepinephrine reuptake inhibitors Duloxetine Thiophenes Shionogi Serotonin–norepinephrine reuptake inhibitor Antidepressant Major depressive disorder Chemistry Organic chemistry Eli Lilly and Company
309	Design, Syntheses and SAR of Inhibitors Targeting the T315I-ABL Mutation Jianguo Cao1, Kathy Barrett2, Richard M. Fine3, Colleen Gritzen1, John Hood2, Jason Kang3, Dan Lohse2, Chi Ching Mak1, Andrew McPherson1, Glenn Nor Add to Reading List Source URL: www.biopredict.com Language: English - Date: 2006-11-28 17:36:48 Piperazines Orphan drugs Pyridines Organofluorides Dasatinib Imatinib Philadelphia chromosome Nilotinib Protein kinase inhibitor Organic chemistry Chemistry Pyrimidines
310	ProNAi Therapeutics Reports Anti-Tumor Activity from Ongoing Phase II Clinical Study of PNT2258, a Novel BCL2-Inhibitor, at ASH Annual Meeting December 09, :00 PM Eastern Standard Time ASH 2013 PLYMOUTH, Mich.--(B Add to Reading List Source URL: www.apjohnventures.com Language: English - Date: 2014-01-07 14:36:35 Apoptosis Bcl-2 Genes Oncology Monoclonal antibody therapy Diffuse large B-cell lymphoma Biology Medicine Lymphoma

UPDATE